Condition: Ridge Augmentation · Sponsor: Datum Dental LTD
This is a prospective randomized controlled parallel trial. The aim of this study is to evaluate bone formation and soft tissue healing after 4 and 8 months in patients with ridge deficiencies in simultaneous implantation approach. The trial will compare a (sugar cross linked) - SCL pericardium membrane OSSIX® Breeze vs native pericardium membrane (Jason®).
This description comes directly from the study's public registry record.
Gavriel Chaushu, prof · +97239377207 · GavrielCe@clalit.org.il
Always discuss trial participation with your own doctor first.
| Hadassah Medical Center | Jerusalem, Israel | Recruiting |
| Rabin Medical Center | Petah Tikva, Israel | Recruiting |
| University of Birmingham | Birmingham, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05584566